These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1159 related articles for article (PubMed ID: 18945595)
1. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Rieg S; Huth A; Kalbacher H; Kern WV Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595 [TBL] [Abstract][Full Text] [Related]
2. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria]. Hasdemir U Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203 [TBL] [Abstract][Full Text] [Related]
5. Directed evolution of a bacterial efflux pump: adaptation of the E. coli TolC exit duct to the Pseudomonas MexAB translocase. Bokma E; Koronakis E; Lobedanz S; Hughes C; Koronakis V FEBS Lett; 2006 Oct; 580(22):5339-43. PubMed ID: 16979625 [TBL] [Abstract][Full Text] [Related]
6. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. Zheng J; Cui S; Meng J J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645 [TBL] [Abstract][Full Text] [Related]
7. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa. Li Y; Mima T; Komori Y; Morita Y; Kuroda T; Mizushima T; Tsuchiya T J Antimicrob Chemother; 2003 Oct; 52(4):572-5. PubMed ID: 12951344 [TBL] [Abstract][Full Text] [Related]
8. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa. Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866 [TBL] [Abstract][Full Text] [Related]
9. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473 [TBL] [Abstract][Full Text] [Related]
10. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide. Puzari M; Chetia P World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273 [TBL] [Abstract][Full Text] [Related]
11. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus]. Cetinkaya E; Coban AY; Durupinar B Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076 [TBL] [Abstract][Full Text] [Related]
12. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798 [TBL] [Abstract][Full Text] [Related]
14. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Cao L; Srikumar R; Poole K Mol Microbiol; 2004 Sep; 53(5):1423-36. PubMed ID: 15387820 [TBL] [Abstract][Full Text] [Related]
15. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850 [TBL] [Abstract][Full Text] [Related]
16. Polyamine effects on antibiotic susceptibility in bacteria. Kwon DH; Lu CD Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056 [TBL] [Abstract][Full Text] [Related]
17. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417 [No Abstract] [Full Text] [Related]
18. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614 [TBL] [Abstract][Full Text] [Related]
19. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa. Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391 [TBL] [Abstract][Full Text] [Related]
20. Effects of a plasmid-encoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes. Jeong JY; Kim ES; Choi SH; Kwon HH; Lee SR; Lee SO; Kim MN; Woo JH; Kim YS Diagn Microbiol Infect Dis; 2008 Jan; 60(1):105-7. PubMed ID: 17889488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]